Vikram Verghese Sells 4,593 Shares of Heartflow (NASDAQ:HTFL) Stock

Key Points

• CFO Vikram Verghese sold 4,593 Heartflow shares at an average price of $50.24, generating $230,752. The transaction was made under a pre-arranged Rule 10b5-1 plan, and he retained 180,196 shares afterward.
• Heartflow shares fell 2.4% to $48.33, despite the company reporting strong quarterly momentum: revenue increased 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than expected.
• Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating, although repeated insider selling—including additional sales by the CFO and CEO—could weigh on the stock in the near term.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CFO Vikram Verghese sold 4,593 shares of the business's stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $50.24, for a total value of $230,752.32. Following the completion of the sale, the chief financial officer owned 180,196 shares of the company's stock, valued at $9,053,047.04. The trade was a 2.49% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The stock was sold at an average price of $50.01, for a total value of $33,406.68.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The stock was sold at an average price of $50.03, for a total transaction of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total transaction of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The shares were sold at an average price of $50.60, for a total value of $297,325.60.

Heartflow Stock Down 2.4%

Shares of NASDAQ HTFL traded down $1.21 during midday trading on Tuesday, reaching $48.33. The company had a trading volume of 2,031,448 shares, compared to its average volume of 1,972,264. The stock has a market cap of $4.20 billion and a PE ratio of -26.41. Heartflow, Inc. has a one year low of $20.13 and a one year high of $51.78. The firm's fifty day moving average price is $36.39 and its 200-day moving average price is $31.21.

Heartflow (NASDAQ:HTFL - Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business had revenue of $64.08 million for the quarter. The business's revenue for the quarter was up 47.7% on a year-over-year basis. As a group, equities research analysts expect that Heartflow, Inc. will post -0.75 EPS for the current year.

More Heartflow News

Here are the key news stories impacting Heartflow this week:

• Positive Sentiment: Heartflow’s latest quarterly results showed strong operating momentum: revenue rose 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than analysts expected. Heartflow stock and earnings information
• Positive Sentiment: Several institutions recently initiated or increased positions, including Squarepoint Ops, which lifted its stake by 72%, providing a potential source of buying support.
• Positive Sentiment: Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating. UBS set a $55 price target, above the recent trading range, while other firms maintained Buy or Overweight ratings.
• Neutral Sentiment: The CFO’s sales were disclosed as part of a planned trading program, reducing the likelihood that the transactions represent a new negative view of Heartflow’s business. After selling 35,?—actually 35,? shares across September 11–15, CFO Vikram Verghese still owned roughly 179,528 shares.
• Negative Sentiment: CFO Vikram Verghese sold a combined 34,975 shares for approximately $1.75 million at prices near $50 per share, reducing his direct ownership by roughly 16.7% over the reported transactions. CFO SEC filing
• Negative Sentiment: CEO John Farquhar also sold 38,900 shares for approximately $1.82 million on September 10–11 and has reported multiple sales since June. The repeated selling by senior executives, particularly after the stock approached its 52-week high, is likely contributing to short-term pressure. HeartFlow CEO share sale

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. XXEC Inc. purchased a new position in shares of Heartflow in the 2nd quarter valued at approximately $2,524,764,000. BlackRock Inc. purchased a new stake in Heartflow in the second quarter worth $152,502,000. Bamco Inc. NY bought a new position in Heartflow in the second quarter worth $94,625,000. Jupiter Topco LLC purchased a new position in Heartflow during the second quarter valued at $70,983,000. Finally, Janus Henderson Group PLC lifted its holdings in shares of Heartflow by 152.0% during the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company's stock valued at $53,063,000 after purchasing an additional 1,315,416 shares during the last quarter.

Analyst Ratings Changes

Several equities research analysts have weighed in on HTFL shares. Robert W. Baird set a $45.00 price target on shares of Heartflow in a research report on Friday, August 14th. UBS Group started coverage on shares of Heartflow in a research report on Wednesday, September 9th. They issued a "neutral" rating and a $55.00 price objective on the stock. Morgan Stanley upped their price objective on shares of Heartflow from $35.00 to $40.00 and gave the company an "equal weight" rating in a research note on Friday, August 14th. JPMorgan Chase & Co. increased their target price on shares of Heartflow from $35.00 to $45.00 and gave the stock an "overweight" rating in a report on Friday, August 14th. Finally, Freedom Capital raised Heartflow to a "strong-buy" rating in a research note on Tuesday, June 30th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $44.88.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries.

The company's primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.